Literature DB >> 17292553

Heparin binding proteins from Leishmania (Viannia) braziliensis promastigotes.

R L Azevedo-Pereira1, M C S Pereira, F O R Oliveria-Junior, R P Brazil, L M C Côrtes, M F Madeira, A L S Santos, L Toma, C R Alves.   

Abstract

We have examined the heparin binding proteins from Leishmania (Viannia) braziliensis promastigotes (HBP-Lb) by chromatography assays. The proposed strategy to isolate an enriched fraction of the HBP-Lb consisted of an association of the Triton X-114 method with affinity chromatography in heparin-Sepharose 4B column. SDS-PAGE analysis of the eluted proteins showed two main protein bands (65.0 and 54.5 kDa), while a single protein band was observed in native electrophoresis gel. The hemagglutination property of HBP-Lb over rabbit erythrocytes was confirmed up to 6.3+/-0.5 microg of protein mL(-1). Additionally, we have assayed the potential of HBP-Lb labeled with sulfo-NHS-LC-biotin in binding to nitrocellulose-immobilized gut proteins extracted of Lutzomyia intermedia and Lutzomyia whitmani. The results indicated a similar profile of five ligands (67.0, 62.1, 59.5, 56.0 and 47.5 kDa) in both studied Lutzomyia species. This is the first direct description of this class of protein in L. (V.) braziliensis with a suggestion of its biological activity in the interaction of Leishmania with Lutzomyia gut cells, which maybe a crucial step during this parasite's life cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292553     DOI: 10.1016/j.vetpar.2006.12.019

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  7 in total

1.  The vectorial potential of Lutzomyia (Nyssomyia) intermedia and Lutzomyia (N.) whitmani in the transmission of Leishmania (V.) braziliensis can also be related to proteins attaching.

Authors:  Carlos R Alves; Luzia M C Côrtes; Reginaldo P Brazil
Journal:  J Biomed Biotechnol       Date:  2010-05-31

2.  Participation of heparin binding proteins from the surface of Leishmania (Viannia) braziliensis promastigotes in the adhesion of parasites to Lutzomyia longipalpis cells (Lulo) in vitro.

Authors:  Luzia Monteiro de Castro Côrtes; Mirian Claudia de Souza Pereira; Franklin Souza da Silva; Bernardo Acácio Santini Pereira; Francisco Odêncio de Oliveira Junior; Renata Oliveira de Araújo Soares; Reginaldo Peçanha Brazil; Leny Toma; Carolina Meloni Vicente; Helena Bonciani Nader; Maria de Fátima Madeira; Felio J Bello; Carlos Roberto Alves
Journal:  Parasit Vectors       Date:  2012-07-17       Impact factor: 3.876

3.  Lipophosphoglycan 3 From Leishmania infantum chagasi Binds Heparin With Micromolar Affinity.

Authors:  Thaís Viana Fialho Martins; Ana Eliza Zeraik; Natália Oliveira Alves; Leandro Licursi de Oliveira; Tiago Antônio de Oliveira Mendes; Ricardo DeMarco; Eduardo de Almeida Marques-da-Silva
Journal:  Bioinform Biol Insights       Date:  2018-03-13

Review 4.  A Promising Candidate: Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction.

Authors:  Yang Yang; Guihuan Liu; Qingnan He; Jie Shen; Linyong Xu; Ping Zhu; Mingyi Zhao
Journal:  J Immunol Res       Date:  2019-12-16       Impact factor: 4.818

5.  Evaluation of macroalgae sulfated polysaccharides on the Leishmania (L.) amazonensis promastigote.

Authors:  Camila Lehnhardt Pires; Selma Dzimidas Rodrigues; Daniel Bristot; Henrique Hessel Gaeta; Daniela de Oliveira Toyama; Wladimir Ronald Lobo Farias; Marcos Hikari Toyama
Journal:  Mar Drugs       Date:  2013-03-20       Impact factor: 5.118

6.  Characterization of a midgut mucin-like glycoconjugate of Lutzomyia longipalpis with a potential role in Leishmania attachment.

Authors:  Jitka Myšková; Anna Dostálová; Lucie Pěničková; Petr Halada; Paul A Bates; Petr Volf
Journal:  Parasit Vectors       Date:  2016-07-25       Impact factor: 3.876

Review 7.  Leishmaniasis and glycosaminoglycans: a future therapeutic strategy?

Authors:  Débora Almeida Merida-de-Barros; Suzana Passos Chaves; Celso Luis Ribeiro Belmiro; João Luiz Mendes Wanderley
Journal:  Parasit Vectors       Date:  2018-10-03       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.